Table 2 Characteristics of patients who developed hepatocellular carcinoma during the initial 12 months of antiviral treatment
Baseline characteristics | Patient 1 | Patient 2 | Patient 3 |
|---|---|---|---|
Sex | F | M | M |
Age | 65 | 55 | 50 |
ALT, U/L | 81 | 30 | 110 |
HBV viral load, IU/mL | 75 | 13 | 10,100 |
Transient elastography, kPa | 29.0 | 20.6 | 75.0 |
Co-infection (HCV/HDV) | No | No | HDV |
Co-morbidity | No | IDDM | IDDM |
Previous antiviral therapy | No | No | No |
Decompensated liver disease | No | Yes | Yes |